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Abstract
Background: With the help of proteomics technology, the human plasma and urine proteomes, which closely represent the
protein compositions of the input and output of the kidney, respectively, have been profiled in much greater detail by
different research teams. Many datasets have been accumulated to form ‘‘reference profiles’’ of the plasma and urine
proteomes. Comparing these two proteomes may help us understand the protein handling aspect of kidney function in a
way, however, which has been unavailable until the recent advances in proteomics technology.
Methodology/Principal Findings: After removing secreted proteins downstream of the kidney, 2611 proteins in plasma and
1522 in urine were identified with high confidence and compared based on available proteomic data to generate three
subproteomes, the plasma-only subproteome, the plasma-and-urine subproteome, and the urine-only subproteome, and
they correspond to three groups of proteins that are handled in three different ways by the kidney. The available
experimental molecular weights of the proteins in the three subproteomes were collected and analyzed. Since the functions
of the overrepresented proteins in the plasma-and-urine subproteome are probably the major functions that can be
routinely regulated by excretion from the kidney in physiological conditions, Gene Ontology term enrichment in the
plasma-and-urine subproteome versus the whole plasma proteome was analyzed. Protease activity, calcium and growth
factor binding proteins, and coagulation and immune response-related proteins were found to be enriched.
Conclusion/Significance: The comparison method described in this paper provides an illustration of a new approach for
studying organ functions with a proteomics methodology. Because of its distinctive input (plasma) and output (urine), it is
reasonable to predict that the kidney will be the first organ whose functions are further elucidated by proteomic methods in
the near future. It can also be anticipated that there will be more applications for proteomics in organ function research.
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Introduction
A large volume of plasma (350–400 mL/100 g of tissue per
min) is filtered by the kidney to generate about 150–180 L/per
day ultrafiltrate, and then most components in the ultrafiltrate are
selectively reabsorbed until less than 1% of the ultrafiltrating
volume is excreted as urine [1]. The physiological processing of
these substances by the kidney is composed of filtration,
reabsorption, and secretion. There have been extensive studies
pertaining to the processing of small molecules by the kidney, such
as glucose, amino acid, sodium, chloride, and water. However,
knowledge about the protein handling function of the kidney was
very limited in the number of proteins studied, which include
lysozyme [2], l-L chain [3], IgG [3], and albumin [4]. A
systematic study of how the kidney handles plasma proteins is not
available yet. With the help of proteomics technology, it can be
studied now with the black box method by comparing the input
and output proteomes, which are well represented by the plasma
and urine proteomes.
Before the proteomics era, proteins in plasma and urine were
identified by enzyme activity experiments, antibody detection, and
microsequencing technology, etc[5,6]. All of the above methods
were time consuming and inefficient. As protein identification was
greatly restricted by technological constraints at that time, it was
very hard to study kidney function by comparing such a limited
number of protein data. Due to advances in mass spectrometry
technology, proteomics methods prominently improved the ability
to identify constituent proteins in complex mixtures. The plasma
and urine proteomes have been profiled in much greater detail by
different research teams [7–14]. Many datasets have been
accumulated to form ‘‘reference profiles’’ of the plasma and urine
proteomes. It is possible now to at least attempt to systematically
study the protein handling part of kidney function by comparing
the plasma and urine proteomes.
PLoS ONE | www.plosone.org 1 April 2009 | Volume 4 | Issue 4 | e5146In this work, the kidney was regarded as a black box with
distinct input and output proteomes. The plasma proteome could
be regarded as the input proteome. However, the urine proteome
could not be simply regarded as the kidney output proteome due
to its complicated protein sources. Urine proteins are derived
largely from kidney filtration and secretion, but they are also
derived from other sources downstream of the kidney as well,
including secretion or shedding from glands and the urine tract
[15,16]. Proteins from these latter sources might complicate the
kidney output. For black box analysis, all input should go into the
black box, and all output should come directly out of the black
box. Anything that can potentially bypass the box should be
removed from the system data. Therefore, for analysis of the
protein handling portion of kidney function, available proteins
secreted into the urine downstream of kidney were subtracted
from the plasma and urine proteomes to form the effective input
and output proteomes, respectively (Figure 1).
By comparing these modified kidney input and output
proteomes, this paper first aims to find which proteins are blocked
or permitted to pass through and which proteins are secreted or
shed from the kidney. Because these different protein handling
pathways in the kidney are closely related to the form and size of
individual proteins, the experimental molecular weights (MWs) of
proteins are therefore important for understanding the mecha-
nisms of protein handling by the kidney. Then the experimental
MWs of the proteins in plasma and urine are compared. Although
much work has been done to identify the plasma and urine
proteins using strategies including one/two-dimensional gel
electrophoresis separation and mass spectrometry, investigators
usually reported protein identifications with only theoretical MWs
without comparing those values with the corresponding experi-
mental values. There are only a limited number of proteins with
experimental MWs published so far in plasma and urine
[10,11,17]. In the future, it is very important to collect as many
experimental data as possible to study kidney functions accurately
and comprehensively, such as experimental molecular weight/
isoelectric point, protein quantities, and posttranslational modifi-
cations.
Data on the plasma and urine proteins identified and analyzed
in this study were obtained from different experiments and from
different human samples. Two assumptions were implied therein
when two proteomes were compared. 1) The plasma and urine
samples procured from different individuals at different physiology
statuses were comparable. To study functions of a particular
kidney, the plasma and urine samples should be acquired from
that individual at that particular time point. If we need to draw a
conclusion from this individual to the general population, we
should assume that the kidney functions of healthy people are
similar. If we assume the kidney functions of healthy people are
similar sooner or later, we think it is reasonable to compare
samples from different healthy individuals from the beginning. 2)
The sensitivity of various plasma and urine protein identification
methods was comparable even though the plasma proteome is far
more complex than the urine proteome. There are certain risks in
comparing the two proteomes. Potential problems of the
hypothesis and solutions will be discussed.
Materials and Methods
Datasets
The Human Proteome Organization Plasma Proteome Project
(HUPO PPP) data were obtained directly from the project website
at the University of Michigan at Ann Arbor (http://www.
bioinformatics.med.umich.edu/hupo/ppp). The 3020 proteins of
the core dataset were downloaded. Another plasma proteome
dataset of 889 proteins with high confidence were obtained from
David J States et al[18]. The plasma protein identifications with
experimental molecular masses were collected by Jin Young Kim
et al [17].
A total of 1543 urinary proteins identified by Matthias Mann
with high confidence were downloaded from http//proteome.
biochem.mpg.de/[14]. The urinary protein identifications with
experimental molecular masses were obtained from Rember
Pieper et al [10] and Jisum Oh et al [11].
The 114 human prostatic secretion proteins were acquired from
Biaoyang Lin et al [19].
Protein sequence database
All protein identifiers presented here were derived from version
3.24 of the International Protein Index (IPI) database [20]
downloaded from ftp://ftp.ebi.ac.uk/pub/database/IPI/old/
HUMAN.
IPI accession number conversion algorithm
Using the IPI history file from ftp://ftp.ebi.ac.uk/pub/databases/
IPI/current/ipi.HUMAN.history.gz, all reported IPI identifiers from
previous versions were converted to IPI version 3.24. The algorithm
employed kept track of multiple chained propagations and only
halted at deletions [21].
Using the human.xrefs files for IPI 3.24 from ftp://ftp.ebi.ac.
uk/pub/databases/GO/goa/HUMAN/, the accession numbers
of urinary proteins other than IPI were converted to IPI version
3.24 accession numbers.
Calculation of theoretical molecular mass
The protein sequences were extracted from IPI 3.24 according
to their accession numbers and then submitted to the website
(http://www.expasy.org/tools/pi_tool.html) to utilize the Com-
pute pI/MW tool to calculate their theoretical molecular masses.
Enrichment analysis of Gene Ontology categories
BiNGO, a plugin of Cytoscape, was used for Gene Ontology
(GO) category enrichment analysis [22]. A custom GO annotation
file for the input-plasma proteome as the reference dataset was
created with instructions on the BiNGO webpage by extracting
the GO annotations available for input-plasma identifiers from
EBI Gene Ontology Annotation (GOA) Human 62.0 release
(http://www.ebi.ac.uk/GOA/). The plasma-and-urine subpro-
teome dataset was tested against the input-plasma proteome
dataset (the reference dataset) for the enrichment analysis. The
analysis was done using the ‘hyper geometric test’, and all GO
terms that were significant with P,0.001 (after correcting for
Figure 1. Kidney function analysis by black box method.
doi:10.1371/journal.pone.0005146.g001
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rate corrections) were selected as overrepresented.
Results
Kidney input proteome and output proteome
The plasma proteome project (PPP) initiated by HUPO in 2002
is an international collaboration to catalog the protein composition
of human blood plasma and serum by analyzing standardized
aliquots of reference serum and plasma specimens [7]. It resulted
in 9504 proteins identified by at least one peptide and in 3020
proteins identified by at least two distinct matching peptides [23].
Recently, there was another research team using a thorough
statistical analysis based on the chances of random matching to a
protein to reduce this list to a set of 889 proteins that can be
considered identified at a confidence level of at least 95%[18].
Considering the confidence and comprehensiveness of the data,
the ‘core dataset’ of 3020 proteins and the high confidence 889
proteins were pooled together to generate 3269 proteins which was
selected as the plasma proteome in this study. It was notable that
all of the proteins had no experimental MWs.
A total of 292 proteins in plasma were identified by Jin Young
Kim et al using both SEQUEST searching[24] and a protein data
filtration method based on correlation (MWcorr) between the
experimental (1-DE) and the theoretical MW[17], although more
than half of the assignments were based on single peptide
identification. Because the potential for erroneous identification
based on single peptide identification is greatly increased, proteins
not present in the plasma proteome selected in this study were
removed from the 292 proteins. Finally, 184 proteins were
acquired as the plasma proteins with experimental MW
information [17].
Matthias Mann and his colleagues provided a high-accuracy
proteome map of urine with high-accuracy mass spectrometry. A
total of 1543 proteins were identified with a high degree of overlap
with a total of about 800 proteins reported before his work [14].
None of the identified proteins had experimental MW information.
The experimental MW information of urinary proteins was
collected from other studies. More than 150 proteins from Rember
Pieper et al [10] and 100 proteins from Jisun Oh et al [11] were
incorporated as the urine proteome with experimental MW
information. Finally, the identifiers from Matthias Mann, Rember
Pieper, and Jisun Oh were pooled together to represent the urine
proteome in this study.
IPI 3.24 was selected as the standard protein database to make
protein accession numbers comparable. All of the previous protein
accession numbers were converted to IPI version 3.24.
After conversion, the whole plasma proteome was reduced from
3269 to 2666 with 1946 unchanged accession numbers, 745
recovered as propagated entries, 578 deleted, and 25 identifiers
lost due to merging. For the 184 proteins of plasma proteome with
experimental MWs, 168 proteins were collected with 147
unchanged, 22 recovered as propagated entries, 15 deleted, and
1 identifier lost due to merging.
For urinary proteins without experimental MWs from Matthias
Mann, 1503 identifiers were recovered with 1453 unchanged
identifiers, 58 propagated, 32 deleted, and 8 lost due to merging.
For urinary proteins with experimental MWs, 97 unique proteins
were obtained from Jisun Oh, and 131 proteins were obtained
from Rember Pieper, after converting their accession numbers
from Swiss-Prot to IPI 3.24. Since 19 proteins were shared in both
datasets, overall 209 unique proteins were adopted from these two
datasets. After removing all of the redundant proteins, protein
identifiers from Matthias Mann, Rember Pieper, and Jisun Oh
were pooled together to generate 1607 proteins as the urine
proteome in this study.
The prostate is a secretory gland downstream of the kidney that
might secrete prostatic fluid into urine, which would influence the
kidney output proteome. Human prostatic secretion proteins
identified by proteomics methods were hence removed from the
urine proteome to generate a valid output proteome [19]. These
prostatic secretion proteins present in urine were also removed
from plasma proteome to generate a valid input proteome,
because it is unclear whether those proteins could be filtered
through the kidney or blocked by kidney and then secreted into
the urine downstream of the kidney. Other proteins that are
possibly incorporated in urine downstream of kidney were
temporarily ignored due to limited knowledge at this time.
Data from Biaoyang Lin et al were the only prostatic secretion
proteome available at this stage [19]. One hundred fourteen
prostatic secretion proteins were converted to a total of 111
proteins with IPI 3.24 accession numbers. Eighty-five of them
were shared in the 1607 urinary-protein dataset, and 27 were
present in the 209 urinary proteins with experimental MWs. All of
these shared proteins were removed from the urinary proteins.
The rest of the proteins were regarded as the kidney urine-output
proteome, which were 1522 proteins for the whole urinary
proteome and a subset of 182 proteins with experimental MWs,
respectively.
There were 55 proteins shared by the 111-protein prostatic
secretion proteome, 1607-protein urine proteome, and 2666-
protein plasma proteome datasets. It was difficult to judge if the 55
proteins went through the kidney or not because the prostate gland
might secrete them into urine. For the purpose of studying the
protein handling aspect of kidney function, all of these proteins
were removed from the plasma proteome, with the rest of the
proteins regarded as the effective plasma-input proteome. It
resulted in 2611 proteins for the whole plasma proteome and 142
proteins for the plasma proteome with experimental MWs.
Based on analysis above, kidney plasma-input proteome and
urine-output proteome were generated. The description of
preparing the two datasets is summarized as table 1.
Three subproteomes from comparing kidney input with
output proteomes
Three subproteomes were generated after comparing the kidney
input and output proteomes, namely, the plasma-only subpro-
teome, the plasma-and-urine subproteome, and the urine-only
subproteome. Then, each protein in the urine-only subproteome
was further manually searched on the plasma proteome website
(http://www.plasmaproteomedatabase.org/query) to determine
whether it is present in plasma. In total, 63 proteins were retrieved
as present both in plasma and urine. Finally, the plasma-only
subproteome consisted of 2280 proteins exclusively in the plasma,
the plasma-and-urine subproteome consisted of 394 proteins
common in both plasma and urine, and the urine-only
subproteome consisted of 1128 proteins exclusively found in urine
(Figure 2, Tables S1, S2, and S3).
In the 142 effective plasma-input proteins with experimental
MWs, there were 69 proteins present exclusively in plasma and 73
proteins present both in plasma and urine. In the 182 effective
urine-output proteins with experimental MWs, there were 131
proteins found only in urine and 51 proteins found both in plasma
and urine. In the plasma-and-urine subproteome composed of 394
proteins described above, there were 16 proteins that had
experimental MWs both in plasma and urine, 57 proteins only
in plasma, and 35 proteins only in urine (Figure 2, Tables S1, S2,
and S3).
Kidney Function by Proteomics
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The function of the kidney can be described in itemized
proteomics language as whether a particular protein is blocked,
permitted to pass, or secreted/shed from the kidney. These three
groups of proteins correspond to the three subproteomes
generated by comparing kidney input and output with the kidney
considered as a black box.
As shown in Figure 2, there were 2280 proteins in the plasma-
only subproteome. Currently, there was no evidence that they
were present in urine based on available proteomic data. These
proteins are supposed to be difficult to pass through the kidney
black box. Experimental MWs of 69 proteins were available,
ranging from 6 kDa to 137 kDa, with 11 of them below 30 kDa.
Thirty-three of these 69 proteins had experimental MWs within
20% variation from the theoretical values, 15 proteins were larger
than 120% of the theoretical MWs, and the remaining 21 were
smaller than 80% of the theoretical values. This included proteins
that could not be filtered at the glomerular capillaries or filtered
but reabsorbed completely back into the blood from the tubules.
Changes in this subproteome may reflect changes in glomerular
and tubule functions.
There were 394 proteins that existed in both plasma and urine.
They may pass the kidney black box in various forms. There were
only 16 proteins with experimental MW information available
from both plasma and urine, which range from 11 kDa to
133 kDa in plasma and 11 kDa to 77 kDa in urine. Comparing
their MWs in plasma and in urine, six proteins were within 20%
variation, suggesting they may pass through the kidney in an intact
form; five had MWs 20% higher in plasma than in urine, and five
had MWs 20% lower in plasma than in urine. These differences
reflect functions of the kidney. Thirty-five of these 394 proteins
had experimental MWs available only in urine, ranging from
15 kDa to 82 kDa, of which 20 were within 20% variation of
theoretical values, 3 were larger than 120%, and 11 were smaller
than 80% of theoretical MWs, and one with multiple fragments
and therefore omitted. Fifty-seven proteins in the plasma-and-
urine subproteome had experimental MWs available only in
plasma, ranging from 6 kDa to 136 kDa, 25 of which were within
20% variation of theoretical values, 18 were larger than 120%,
and 14 were smaller than 80% of theoretical MWs. At this stage,
we could not distinguish proteins filtered at the glomerular
capillaries from those that were blocked at the glomerular
capillaries but also secreted or shed from the kidney into the urine.
It is believed that proteins with a MW of ,15 kDa are freely
filtered in the glomeruli; proteins up to 45 kDa are quite rapidly
filtered and proteins between 45 to 60 kDa only restrictedly.
Table 1. Summary of the preparation of the plasma-input proteome and urine-output proteome for comparing.
Plasma-input proteome
Without(with) experimental MW
Urine-output proteome
Without(with) experimental MW
Human prostatic secretion
proteins
Before conversion 3269(184) 1543(150
[1]+100
[2]) 114
Converted to IPI V3.24 2666(168) 1503(131
[1]+97
[2]) 111
Sum 2666(168) 1607(209)
Removing prostatic secretion proteins 2611(142) 1522(182)
[1]Pieper R, Gatlin CL, McGrath AM, Makusky AJ, Mondal M, et al. (2004) Characterization of the human urinary proteome: a method for high-resolution display of urinary
proteins on two-dimensional electrophoresis gels with a yield of nearly 1400 distinct protein spots. Proteomics 4: 1159–1174.
[2]Oh J, Pyo JH, Jo EH, Hwang SI, Kang SC, et al. (2004) Establishment of a near-standard two-dimensional human urine proteomic map. Proteomics 4: 3485–3497.
doi:10.1371/journal.pone.0005146.t001
Figure 2. Diagram of proteins found in the three subproteome datasets. There are 2280 proteins in the plasma-only subproteome (red), 394
proteins in the plasma-and-urine subproteome (orange), and 1128 proteins in the urine-only subproteome (yellow). The proteins in blue circles (142
proteins) and green circles (182 proteins) represent effective input-plasma proteins with experimental MWs and effective output-urine proteins with
experimental MWs, respectively. Numbers represent the number of shared proteins in the respective overlapping areas.
doi:10.1371/journal.pone.0005146.g002
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kidney[25]. We found some proteins with experimental
MW,45 kDa exist in the plasma but have not been identified
in the urine proteomic data until now. There were some possible
mechanisms. For example they might bind to larger carrier
proteins or there might be some unknown mechanisms for them to
be retained for an extended period in the plasma. We have also
found that some proteins with experimental MW.60 kDa had
been identified both in plasma and urine such as IPI00020996
(experimental molecular weight 80 kDa in plasma and 77 kDa in
urine) and IPI00291866 (experimental molecular weight 91 kDa
in plasma and 75 kDa in urine). These proteins might be secreted
but the passing through the glomeruli could not be ruled out. This
is worth of further study.
One thousand one hundred twenty-eight proteins were
identified only in urine, but not in plasma, by proteomics methods.
Proteins secreted or shed from the kidney are thought to be
included in this group. Since the plasma proteomic data were
filtered with high stringency, there were potentially a lot of false
negative proteins. In other words, some of the 1128 proteins might
exist in plasma but were missed because of the stringent filtering
criteria, so they may have been determined to belong to plasma-
and-urine subproteome instead of urine-only one. One hundred
thirty-one of these proteins had experimental MWs available,
ranging from 10 kDa to 120 kDa, in which 97 were within 20%
variation of their theoretical values, 7 were larger than 120%, and
25 were smaller than 80% of the theoretical MWs, and 2 were
omitted due to the existence of multiple fragments. Changes in the
urine-only subproteome may reflect functional changes of the
kidney directly.
In the urine data, there were a total of 182 proteins with
experimental MWs available. One hundred twenty-six of them
had experimental and theoretical MWs within 20% difference,
suggesting that a high percentage of urinary proteins probably
existed in intact forms in urine (data not shown). The distribution
of theoretical MWs for the three subproteomes is shown in
Figure 3. Because the variance between theoretical and experi-
mental MWs was not very big in the urine data with experimental
MWs available, the theoretical MW distributions might roughly
correlate to the true MW distributions of these three subpro-
teomes. It was notable that many small proteins in the plasma-only
subproteome were blocked from passing the kidney. Since post-
translational modifications generally increase the actual MW of a
protein by no more than 10–40% [17], blockage of those small
proteins lower than 30 kDa in the plasma-only subproteome may
involve mechanisms other than molecular weight, such as
molecular charge, molecule shape, or interaction with other
proteins.
Gene Ontology term enrichment analysis for plasma-and-
urine subproteome against Input-plasma proteome
The kidney has been shown to regulate the concentration of
many biologically active proteins in the plasma and to play an
important role in the disposal of circulating small proteins [26–30].
We believe that the functions of the overrepresented proteins in
the plasma-and-urine subproteome are the major functions that
can be routinely regulated by excretion from the kidney in
physiological conditions. The Gene Ontology project provides a
controlled vocabulary for describing a protein in terms of its
molecular function, biological process, or subcellular localization
[31]. We used the Biological Networks Gene Ontology (BiNGO)
program package to search for GO terms statistically overrepre-
sented in the plasma-and-urine subproteome versus the whole
plasma proteome [22]. The plasma proteins (2674 proteins) were
regarded as the reference dataset in the enrichment analysis. A
custom GO annotation file for the reference dataset was created
with the instructions on the BiNGO webpage (http://www.psb.
ugent.be/cbd/papers/BiNGO).
As shown in Figure 4, in the cellular component category, six
GO terms were overrepresented, they were the extracellular
region, the extracellular region part, the extracellular space, the
extracellular matrix, the proteinaceous extracellular matrix, and
the plasma membrane part. All of them were enriched in the ‘core
dataset’ plasma proteome at the same significance level [32]. This
suggests that many extracellular proteins and plasma membrane
proteins in plasma pass through the kidney into the urine and that
these proteins were probably eliminated by excretion into the
urine. On the other hand, many proteins whose functions were
associated with the nucleus, cytoskeleton, intermediate filaments,
and collagen were overrepresented in the ‘core dataset’ of the
plasma proteome [32] but were not enriched in the plasma-and-
urine proteome. In the molecular function category (Figure 5), 12
GO terms were enriched in the plasma-and-urine proteome, with
nine terms emphasizing the enzyme activity or enzyme inhibitor
activity categories and three that include calcium ion binding,
growth factor binding, and insulin-like growth factor binding. The
GO terms enrichment analysis suggested that many proteins
related to enzyme regulation, calcium ion binding, and growth
factor binding in plasma were also excreted. This could be a
mechanism for regulation of the functions of these proteins in the
human body. For terms related to biological processes (Figure 6),
28 terms were overrepresented in the plasma-and-urine proteome,
including those associated with response to stimulus, the immune
system, stress responses, inflammation, wound repair, and
coagulation. These biological processes probably could be
regulated and affected by kidney function too.
There were many proteins enriched in the plasma-and-urine
proteome. There might be a regulatory mechanism performed by
the kidney to quickly and precisely regulate the quantity of these
proteins within a narrow range in plasma. The regulation may be
vital to the survival of the body. Therefore, the quantity of these
proteins in the urine can vary to keep homeostasis in the plasma.
Since their quantities probably change constantly under physio-
logical conditions, they might not be good candidates for disease
biomarkers.
Discussion and perspective
Since mass spectrometry-based proteomics was founded, body
fluid proteomes, such as plasma, urine, tear, and cerebrospinal
fluid, have been profiled by many groups. However, all of the body
fluids interact with each other and many organs and collectively
contribute to form a dynamic system in the body. For instance,
plasma may influence most other body fluids, such as urine,
cerebrospinal fluid, and tears. It is important to analyze the
proteomes of various body fluids in the context of plasma. Normal
urinary proteins were considered to reflect normal kidney
physiology because the urinary proteome contains not only plasma
proteins but also kidney proteins [8–14,33]. Pisitkun et al thought
Urinary proteins include glomerular filtrated plasma proteins,
soluble proteins secreted by epithelial cells, and solid phase
elements of epithelial cells and other cell sources and exo-
somes.[15] Another study of urine collected from normal human
adult subjects indicated that ,48% of the total urinary proteins
excreted was contained in sediments, 49% was soluble, and the
remaining 3% was in exosomes [34]. Based on the analysis above,
the plasma-only subproteome was derived mainly from the soluble
proteins that could not pass the kidney and solid phase
components in the plasma; the plasma-and-urine subproteome
Kidney Function by Proteomics
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and epithelial cell secretion of soluble proteins; the urine-only
subproteome was derived mainly from the epithelial cell secretion
of soluble proteins and solid phase components in urine.
Proteins in the plasma-and-urine subproteome were excreted
into urine, which constitutes a loss of substance. As an organ that
serves to keep the homeostasis of the internal environment, the
kidney’s function of excreting some proteins from plasma is well
conserved during evolution. By Gene Ontology enrichment
analysis, we found that many enzymes, enzyme inhibitors, calcium
and growth factor binding proteins, and proteins involved in other
biological processes were excreted by the kidney. This suggests
that plasma levels and/or plasma half-lives of these proteins can be
regulated by the kidney. For instance, proteases are important to
Figure 3. Theoretical molecular weight distributions for the three subproteomes, plasma-only subproteome, plasma-and-urine
subproteome, and urine-only subproteome.
doi:10.1371/journal.pone.0005146.g003
Figure 4. Significantly overrepresented GO cellular component terms for the set of plasma-and-urine proteins. The plasma-and-urine
proteins were compared with the entire list of plasma proteins (2674 proteins), and significantly over-represented GO terms (P,0.001) are shown.
The ratio shown is the number of plasma-and-urine proteins and total plasma proteins annotated for each GO term divided by the number of
plasma-and-urine proteins and total plasma proteins linked to at least one annotated term within the indicated GO cellular component, molecular
function, and biological process categories. GO, Gene Ontology.
doi:10.1371/journal.pone.0005146.g004
Kidney Function by Proteomics
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them are vital to the survival of the body. They need to be
regulated quickly and precisely in the plasma, even at the cost of
substance loss.
Though proteomics has been improving rapidly, it is probably
still far from being capable of exhaustively identifying proteins in
plasma and urine. Here, the comparison method described in this
paper provides an illustration of a new approach for studying organ
functions with a proteomicsmethodology. In the future, plasma and
urine samples from one individual at the same time point can be
characterized for the study of an individual’s kidney function. Sex
specific proteins, presumably coming from sex specific glands, can
be identified if the male and female proteomes are profiled
separately and they should be removed from the kidney output
proteome for the black box study of kidney function. It would be
better to compare the two proteomes using unbiased quantitative
proteomics techniques. However, such studies are not available yet.
With further development of proteomics technologies, i.e., quan-
titative-MS-based proteomics, top-down strategy proteomics, and
antibody arrays, and improvement in the data quality, such
comparisons will presumably result in more meaningful and valid
conclusions. More detailed descriptions of kidney functions can be
obtained by comparing two or more proteomes with more
exhaustive and reliable protein information, such as complete
MWs, pIs, posttranslational modifications, and quantitation.
Because of its distinctive input (plasma) and output (urine), it is
reasonable to predict that the kidney will be the first organ whose
functions are further elucidated by proteomic methods in the near
future. It canalsobe anticipatedthat there will be more applications
for proteomics in organ function research.
Figure 5. Significantly overrepresented GO molecular function terms for the set of plasma-and-urine proteins. Each term was selected
as described in Figure 4. GO, Gene Ontology.
doi:10.1371/journal.pone.0005146.g005
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